<DOC>
	<DOCNO>NCT01485250</DOCNO>
	<brief_summary>Background : - Individuals often participate clinical trial seek new therapy free medical treatment illnesses chronic condition . However , less known motivation healthy individual volunteer research study . - Although many healthy volunteer participate clinical trial financial compensation , particular risk involve test drug try human clinical trial pose potential danger healthy volunteer Phase I study . More research need understand motivation volunteer participate Phase I clinical trial . Objectives : - To evaluate primary secondary motivation healthy participant research study . Eligibility : - Individuals least 18 year age healthy volunteer select Pfizer Phase I clinical trial . Design : - Individuals express interest participate specific Pfizer Phase I drug study ask complete short questionnaire complete standard consent session study . - Those enroll trial ask complete second questionnaire prior discharge study .</brief_summary>
	<brief_title>A Cross-Cultural Assessment Motivations Healthy Participants Phase I Research</brief_title>
	<detailed_description>This healthy volunteer motivation study sub-study Phase I drug development study conduct Pfizer International . The substudy design evaluate primary secondary motivation healthy participant research study , well process participant decide participate , include consideration risk , benefit , compensation factor , relationship factor cultural sociodemographic variable . Data collect via self-administered survey 2 possible time point , 1 ) go consent process begin participation primary study , 2 ) towards end study participation .</detailed_description>
	<criteria>INCLUSION CRITERIA : Participants willing adult participate informed consent session designate Phase I study Pfizer CRU . Participants New Haven Singapore must able read answer question English participant Brussels must able read answer question either English , French , Flemish . Only adult ( 18 year old ) provide consent include . EXCLUSION CRITERIA : Participants Pfizer phase I study unable unwilling complete survey instrument .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 31, 2016</verification_date>
	<keyword>Healthy Volunteers</keyword>
	<keyword>Motivations</keyword>
	<keyword>Decision Making</keyword>
	<keyword>Motivation</keyword>
</DOC>